Atara Biotherapeutics (ATRA) EPS (Basic) (QoQ) (2013 - 2026)
Atara Biotherapeutics (ATRA) EPS (Basic) (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Atara Biotherapeutics | 141.91 Mn | 125.36 Mn | 439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.62% |
| Mar 31, 2026 | -8.99% |
| Dec 31, 2025 | 14.86% |
| Sep 30, 2025 | -262.10% |
| Jun 30, 2025 | -94.46% |
| Mar 31, 2025 | 308.32% |
| Dec 31, 2024 | 42.24% |
| Sep 30, 2024 | 5.37% |
| Jun 30, 2024 | 45.08% |
| Mar 31, 2024 | 60.43% |
| Dec 31, 2023 | 12.99% |
| Sep 30, 2023 | 3.05% |
| Jun 30, 2023 | 5.91% |
| Mar 31, 2023 | 1.64% |
| Dec 31, 2022 | 10.94% |
| Sep 30, 2022 | -551.73% |
| Jun 30, 2022 | 120.78% |
| Mar 31, 2022 | 12.42% |
| Dec 31, 2021 | -10.42% |
| Sep 30, 2021 | 0.53% |